We are live on ! Find out more
PARN

Parnell Pharmaceuticals Holdings Ltd
PARN

Delisted

PARN was delisted on the 30th of December, 2016.

Back to rankings

16 hedge funds and large institutions have $17.6M invested in Parnell Pharmaceuticals Holdings Ltd in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $16.1M → $17.6M (+$1.42M)

11% less funds holding

Funds holding: 18 → 16 (-2)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ECM
Endurant Capital Management
California
+$174K
2
JP Morgan Chase
JP Morgan Chase
New York
+$60.3K
3
BIM
BlackRock Investment Management
Delaware
+$37.2K
4
TRCT
Tower Research Capital (TRC)
New York
+$6.12K
5
LTFS
Ladenburg Thalmann Financial Services
Florida
+$1.39K

Top Sellers

1
DM
Deerfield Management
New York
-$565K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$482K
3
UOC
UBS O'Connor
Illinois
-$204K
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$161K
5
Deutsche Bank
Deutsche Bank
Germany
-$146K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$4.01M – – –
BA
2
BlackRock Advisors
Delaware
$2.66M – – –
AG
3
Artal Group
Luxembourg
$2.46M – – –
ECM
4
Endurant Capital Management
California
$1.41M +$174K +37,736 +15%
AIC
5
AWM Investment Company
New York
$1.34M – – –
DM
6
Deerfield Management
New York
$1.25M -$565K -122,108 -33%
BG
7
BlackRock Group
United Kingdom
$1.25M -$26.8K -5,800 -2%
PA
8
Perceptive Advisors
New York
$964K -$81.4K -17,600 -8%
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$763K -$161K -34,897 -18%
BIM
10
BlackRock Investment Management
Delaware
$421K +$37.2K +8,047 +10%
JP Morgan Chase
11
JP Morgan Chase
New York
$414K +$60.3K +13,035 +18%
UOC
12
UBS O'Connor
Illinois
$386K -$204K -44,219 -36%
Goldman Sachs
13
Goldman Sachs
New York
$223K -$3.24K -700 -2%
TRCT
14
Tower Research Capital (TRC)
New York
$11K +$6.12K +1,324 +162%
LTFS
15
Ladenburg Thalmann Financial Services
Florida
$1K +$1.39K +300 New
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
– -$482K -116,498 Closed
Deutsche Bank
17
Deutsche Bank
Germany
– -$146K -35,240 Closed
UBS Group
18
UBS Group
Switzerland
– -$1K -251 Closed

PARN Hedge Fund Activity: Q1 2015 in Review

16 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Parnell Pharmaceuticals Holdings Ltd (PARN) for Q1 2015, worth a combined $17.6M — up 8.8% from $16.1M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PARN and 1 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 4 added.

The largest buyer was Endurant Capital Management, adding an estimated $174K. The largest seller was Deerfield Management, cutting an estimated $565K.

  • 16 institutional investors held Parnell Pharmaceuticals Holdings Ltd (PARN) as of Q1 2015, down from 18 in Q4 2014.
  • Funds reported $17.6M of Parnell Pharmaceuticals Holdings Ltd stock for Q1 2015, up 8.8% quarter-over-quarter.
  • 1 fund opened new Parnell Pharmaceuticals Holdings Ltd positions in Q1 2015 and 3 closed out, a net change of -2 holders.
  • The largest Parnell Pharmaceuticals Holdings Ltd buyer in Q1 2015 was Endurant Capital Management, an estimated $174K added.
  • The largest Parnell Pharmaceuticals Holdings Ltd seller in Q1 2015 was Deerfield Management, an estimated $565K sold.

Based on aggregated 13F filings for Q1 2015.